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The article by Bacic et al. [1] (link to http://dx.doi.org/10.1016/j.
redox.2015.10.007) provides an overview on the application of
magnetic resonance imaging (MRI) and electron paramagnetic
resonance (EPR) spectroscopy of stable nitroxide radicals to
monitor metabolically induced changes in the redox status of or-
gans. These techniques will not only contribute to the mechanistic
understanding of oxidative stress-associated pathological states
but also provide a basis for studying the effectiveness of inter-
ventions aimed to modulate oxidative stress (redox medicine ap-
proaches). The authors introduce the different MRI and EPR
methods that are currently available and describe a broad spec-
trum of nitroxide-based spin traps and spin probes with emphasis
on pharmacokinetic properties. In the second part of the review,
the authors provide examples for the application of these techni-
ques to study changes in the redox status in different tissues (e.g.
skin, brain, tumors) upon induction of disease states (e.g. sepsis,
ischemia/reperfusion, iron overload). With their conclusions, the
authors provide an outlook on future technical needs and devel-
opment of new probes with increased stability towards reduction,
enhanced sensitivity to oxidative stress, or increased delivery into
cells and through the blood–brain barrier as well as speciﬁcity
towards certain ROS species or speciﬁcity towards certain
pathologies such as tumors.
The review by Dunn et al. [2] (link to http://dx.doi.org/10.1016/
j.redox.2015.09.005) discusses different pathways of bacterially-
induced mtROS formation and its role for activation of the NLRP3
inﬂammasome via direct redox modiﬁcations of the NLRP3 com-
ponents as well as redox-sensitive indirect pathways such as Nrf2/
HO-1, NFκB/iNOS and TXNIP/mtDAMP interaction with the NLRP3
inﬂammasome leading to the formation of the pro-inﬂammatory
cytokine IL-1β. Mitochondrial damage-associated molecular pat-
terns (mtDAMPs) include the participation of mtDNA and/or car-
diolipin that are released or surfaced by dysfunctional mitochon-
dria. This also results in decreased activity of NADþ-dependent
deacetylases Sirt1 and Sirt2 that normally inhibit NFκB and NLRP3
activation. ROS in general also contribute to extracellular trap
formation originating from nuclear or mitochondrial DNA.
The review by Espinosa-Diez et al. [3] (link to http://dx.doi.org/
10.1016/j.redox.2015.07.008) highlights the adaptive cellular anti-
oxidant responses to oxidative stress. In the ﬁrst part, the role and
function of classical thiol-based antioxidant proteins such as GCL,
Grx, GPx, Prx, Trx, GST, GR and TrxR are discussed. In addition, the
antioxidant gene response is discussed with the classical examplesx.doi.org/10.1016/j.redox.2015.12.007
17/& 2015 The Authors. Published by Elsevier B.V. This is an open access article uof Nrf2/Keap1, NFκB, AP-1 and the epigenetic pathway based on
miRNA. A detailed list of miRNA targeting of speciﬁc antioxidant
genes and the respective disease states in which the miRNA action
was described is provided by the authors. In the last part, these
antioxidant responses are discussed in the context of pathophy-
siological conditions (ER stress and ischemia reperfusion). The
major key players in this redox regulatory network of antioxidant
responses are ﬁnally presented (e.g. protein tyrosine phospha-
tases, protein kinases), the important role of mitochondrial ROS in
this network is highlighted and therapeutic targeting of mtROS is
discussed.
The review by Görlach et al. [4] (http://dx.doi.org/10.1016/j.re
dox.2015.08.010) provides insight into the impact of calcium levels
on ROS sources such as mitochondria and NADPH oxidases. Vice
versa, the role of oxidative stress on different types of calcium
channels and pumps is discussed in full detail. In the second part
of the review, the authors elaborate on the interaction (crosstalk)
of calcium and ROS in the endoplasmic reticulum and mitochon-
dria. In summary, the authors provide evidence that calcium can
increase the production of ROS and these ROS can signiﬁcantly
affect calcium inﬂux into the cell and intracellular calcium stores.
The second review by Görlach et al. [5] (http://dx.doi.org/10.
1016/j.redox.2015.08.016) highlights the sources of ROS in differ-
ent cellular compartments such as plasma membrane, cytosol,
endoplasmic reticulum, mitochondria, peroxisomes and lysosomes
(e.g. NADPH oxidases, xanthine oxidase, P450s, lipoxygenase, cy-
clooxygenase, lipid peroxidation, phospholipase, acyl-CoA oxi-
dases, polyamine oxidase, Ero1 and liposomal redox chain) and
provides an update on all NADPH oxidase isoforms (subcellular
localization, cellular expression and cofactors). In addition, the
authors emphasize on ROS-triggered signaling via redox-sensitive
kinases (e.g. PKC, Akt and MAPK) and protein tyrosine phospha-
tases, transcription factors (e.g. NFκB, Nrf2 and HIF-1α). In the last
part of the review, they discuss these concepts in the context of
hypoxia, nutrition, energy metabolism and metabolic
reprogramming.
The review by Jankovic et al. [6] (http://dx.doi.org/10.1016/j.re
dox.2015.08.018) provides detailed insights in the physiological
function of adipocytes and the ratio and interconversion between
white and brown adipose tissue, as well as the physiological
consequences of this interconversion. Nutritional shifts in
NADþ/NADH ratio affect the redox balance in adipose tissue and
overnutrition, oxidative stress and mitochondrial dysfunction
contribute to adipocyte dysfunction, which is more concerning
than fat accumulation per se. Dysfunctional adipocytes alsonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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inﬂammation with more pronounced ROS formation. Sources of
ROS in dysfunctional adipocytes are highlighted, the interaction
and co-stimulation of these ROS sources in a crosstalk fashion is
detailed while the impact of mtROS in insulin resistant adipocytes
and the important role of NO formation in functional adipocytes
versus uncoupled eNOS in dysfunctional adipocytes is thoroughly
discussed. Finally, the authors analyze the role of redox signaling
in adipogenesis.
The review by Klotz et al. [7] (http://dx.doi.org/10.1016/j.redox.
2015.06.019) delves into FoxO transcription factors by addressing
their classical regulation (e.g. by insulin), the FoxO target genes
(e.g. selenoprotein P, ceruloplasmin) conferring antioxidant pro-
tection and their regulation via phosphorylation by different ki-
nase systems (Akt, ERK, JNK, MAPK, AMPK, most of them are re-
dox-sensitive). The authors also emphasize the biological effects of
FoxO activation. In the second part of the review, the different
redox-regulatory pathways of FoxO transcription factors are re-
capitulated (FoxO gene induction, posttranscriptional regulation of
FoxO expression levels, FoxO activity). In the last part, the authors
highlight physiological and pathophysiological consequences of
FoxO (dys)regulation (e.g. in obesity and diabetes) as well as dis-
sect the interaction of FoxO and ROS in different organs and cell
types.
The review by Manda et al. [8] (http://dx.doi.org/10.1016/j.re
dox.2015.06.014) provides an introduction on cancerogenesis with
emphasis on the contribution of oxidative stress to this process,
highlighting impaired DNA damage repair as one important con-
stituent of cancer development. Redox signaling networks are
unbalanced in cancer cells. As examples the activities of mitogen-
activated protein kinases, FoxO transcription factors and Nrf2/
Keap1 system are dysregulated in cancer cells, conferring higher
oxidative stress resistance. In line with increased oxidative stress
but also oxidative stress resistance of tumor cells, the hyperin-
ﬂammation observed in tumor tissue (originating from inﬁltrated
immune cells but also cytokines produced by speciﬁc cancer cells),
contributes to tumor growth (e.g. increased cancer cell prolifera-
tion, angiogenesis). Therefore, oxidative stress-based therapies
might include the suppression of antioxidant transcription factors
(e.g. Nrf2 inhibitors). The authors also discuss the types of cell
death induced by oxidative stress-based therapies. For an in-depth
review of the dysregulation of the Keap1-Nrf2 pathway in cancer,
the readers are also referred to an earlier graphical redox review
by Kansanen et al. [9] (http://dx.doi.org/10.1016/j.redox.2012.10.
001), which now forms part of this thematic virtual collection.
The review by Manea et al. [10] (http://dx.doi.org/10.1016/j.re
dox.2015.06.012) provides an overview on NADPH oxidase iso-
forms in different cell types and their pathophysiological actions in
vascular inﬂammation and oxidative stress, vascular dysfunction
and remodeling and ﬁnally progression to atherosclerosis. The
authors highlight the milestones of the yet incompletely under-
stood regulation of Nox enzyme expression by transcription fac-
tors and nuclear receptors (e.g. NF-kB, AP-1, STAT1/3, C/EBP and
PPARs). In addition, epigenetic pathways are discussed accounting
for Nox4 upregulation (e.g. miRNA-25, HATs and HDACs).
The review by McBean et al. [11] (http://dx.doi.org/10.1016/j.
redox.2015.04.004) summarizes thiol-based cellular redox couples
(e.g. sulﬁredoxin, Trx, Prx, Grx) and links them to the respective
reductases and cofactors (e.g. TrxR, GR, NADPH, GSH) as well as to
the transcription factors accounting for their induction (e.g. Nrf2,
AP1, FoxO). The L-cysteine metabolism is discussed in detail,
starting at the level of the L-cystine xc- exchanger, the homo-
cysteine cycle and the synthesis of GSH, H2S and taurine, with
special emphasis on neurodegenerative disease. In the second
part, the authors discuss these thiol-based pathways in the context
of glaucoma and neurodegeneration with focus on Grx, Trx andPrx as neuronal survival factors. The last part of the review high-
lights the role of impaired redox balance for neurodegeneration
with particular reference to Alzheimer's disease, Parkinson's dis-
ease, amyotrophic lateral sclerosis and glaucoma.
The review by Mikhed et al. [12] (http://dx.doi.org/10.1016/j.
redox.2015.05.008) provides an overview on classical gene reg-
ulation, epigenetic pathways and components of the DNA repair
machinery. In the second part the authors discuss in full detail
examples of redox regulation of classical gene expression (e.g. by
redox sensitive transcription factors such as NFκB, Nrf2 and HIF-
1α or mRNA-binding proteins GAPDH or HuR) leading to activa-
tion of gene expression and/or modulation of mRNA stability,
thereby affecting protein expression. In addition, the impact of
ROS on DNA repair and epigenetic pathways (e.g. miRNA, DNA
methylation and histone modiﬁcations) is highlighted, all of which
will inﬂuence the genome stability. In the last part of the review
the authors discuss clinical implications of these concepts and
therapeutic strategies to target dysregulated DNA repair and
classical gene regulation, but also expand on pharmacological
modulation of epigenetic gene regulation (e.g. HDAC, HAT and
DNMT inhibitors and modulators of miRNA function).
The original article by Mikhed et al. [13] (http://dx.doi.org/10.
1016/j.redox.2015.11.008) highlights the special features of salicy-
laldehyde as a new probe for the detection of physiological for-
mation rates of peroxynitrite in the nanomolar range. In contrast
to previously described phenolic compounds such as phenol or L-
tyrosine that yield mainly dimerization products when incubated
in the free form with low ﬂuxes of peroxynitrite, salicylaldehyde
forms nitrated products (e.g. 2-nitrophenol) and only minor
amounts of dimers with peroxynitrite donors such as Sin-1. This
speciﬁc property together with the fact that nitric oxide alone or
peroxidase/hydrogen peroxide/nitrite only generate trace amounts
of nitrated products when present at physiological concentrations,
provides salicylaldehyde with a unique capability for the detection
of peroxynitrite in vivo.
The original article by Noichri et al. [14] (http://dx.doi.org/10.
1016/j.redox.2015.08.011) addresses the mechanism of how per-
oxiredoxin function switches from peroxidase to chaperon. In the
Prx peroxidase cycle, a homodimer reacts with hydrogen peroxide
to yield a sulfenic acid modiﬁed thiol group in each subunit,
leading to intermolecular disulﬁde bridge formation and dimer-
ization of the loosely bound reduced homodimer. The “disulﬁde
form” is reduced by Trx and oxidized Trx is reactivated by TrxR/
NADPH. However, the “disulfenic acid form” can be further oxi-
dized by hydrogen peroxide to a “disulﬁnic acid form”, which
needs ATP-dependent reduction by sulﬁredoxin. The loss of its
peroxidase activity and inactivation of Prx by hyperoxidation
provides the basis for its extra-antioxidant functions, and in par-
ticular its ability to operate as very efﬁcient chaperone holdases.
This process is initiated by formation of high molecular weight Prx
structures formed by the stacking of Prx decamers up to ﬁlaments
an event that correlates with enzyme hyperoxidation but is not
fully understood. The authors used mutation approaches and size
exclusion chromatography to elucidate the nature of the different
high molecular weight forms of Prx and investigated the different
binding modes within these structures and the correlation with
hyperoxidation. With their results, the authors contribute to the
molecular understanding of the Prx peroxidase to chaperone
modes switch.
The review by O'Neill et al. [15] (http://dx.doi.org/10.1016/j.re
dox.2015.07.009) concentrates on the role of ROS for genetic dis-
ease such as Nox2 subunit-deﬁciencies in chronic granulomatous
disease (CGD) and discuss the paradox of the absence of ROS and
simultaneous hyperinﬂammation in CGD. Neuronal, cardiovascular
and renal pathologies of CGD are presented in detail. Methods for
clinical analysis of new genetic variants of Nox2 in CGD as well as
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tion of pluripotent stem cells). In the second part of the review, the
authors highlight the aspects of inﬂammatory bowel disease, its
association with reduced ROS formation and the role of Nox1 and
Duox2 isoforms. Finally, the role of Duox2 and A2 isoforms for the
development and progression of hypothyroidism, which is the
most common congenital endocrine disorder, is elucidated on a
mechanistic basis and a detailed list of gene variants of Duox2 and
A2 is provided.
The review by Pajares et al. [16] (http://dx.doi.org/10.1016/j.re
dox.2015.07.003) provides an overview on the impact of oxidative
stress and redox modiﬁcations on the proteasomal activity, high-
lighting classical examples such as hydroxylation-triggered HIF-1α
degradation, oxidative Nrf2 stabilization and nuclear translocation,
but also the canonical pathway of NFκB activation by ubiquitina-
tion and proteasomal degradation of its inhibitor (IκBα). Also de-
scribed are more recent developments incorporating the role of
direct redox modiﬁcations of proteasomal components, the inter-
action of oxidative stress with autophagy and proteasome activity
and the impact of protein unfolding/misfolding on ROS formation
and proteasome activity. In the last part of the review the authors
discuss clinical implications of these concepts in neurodegenera-
tive diseases (Prion, Alzheimer's and Parkinson's disease).
The original article of Semen et al. [17] (http://dx.doi.org/10.
1016/j.redox.2015.11.009) investigates the effects of sildenaﬁl
(PDE-5 inhibitor) therapy on heart rate variability, fatty acid
composition and 4-hydroxynonenal (as a read-out of oxidative
stress) in patients with pulmonary arterial hypertension (PAH).
PAH is characterized by a poor prognosis with a mortality rate of
10–15% per year and median survival of approximately 7 years
upon ﬁrst diagnosis. PAH is associated with increased oxidative
stress, reduced NO and prostacyclin bioavailability, excessive for-
mation of vasoconstrictors and an inﬂammatory phenotype of the
vascular wall. Sildenaﬁl partially compensates for impaired vaso-
dilatory pathways and confers antioxidant and anti-inﬂammatory
effects. Sildenaﬁl therapy improved the pulmonary hemodynamic
status, oxidative stress, normalized free fatty acid composition and
partly also heart rate variability.
The review by Voskou et al. [18] (http://dx.doi.org/10.1016/j.re
dox.2015.07.018) highlights the role of oxidative stress in β-tha-
lassemia and sickle cell disease. The phenotype of the diseases is
described in full detail with focus on the sources of oxidative stress
in red blood cells in this setting. ROS formation is mainly driven by
autoxidation of hemoglobin and free iron leads to Fenton chem-
istry. To a minor extent NADPH oxidases account for ROS forma-
tion in red blood cells. The intracellular oxidative events in dis-
eased red blood cells and the counter-regulatory mechanisms by
antioxidant systems are presented. The authors provide mechan-
istic insights into ROS-driven hemolysis, impairment of ery-
thropoiesis and oxidative stress-mediated erythroid expansion
and accelerated differentiation. The extracellular oxidative stress
in β-thalassemia and sickle cell disease leads to a vicious cycle of
oxidative stress and inﬂammation as well as a hypercoagulability
state. Reduced NO bioavailability is a direct consequence of in-
creased superoxide formation but also increased break-down of
NO by sequestered myeloperoxidase/hydrogen peroxide from
neutrophils and increased consumption of NO by free oxyHb from
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